Literature DB >> 8117275

Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.

N Hama1, H Itoh, G Shirakami, S Suga, Y Komatsu, T Yoshimasa, I Tanaka, K Mori, K Nakao.   

Abstract

We have previously reported that C-type natriuretic peptide (CNP), the third member of natriuretic family, was produced in vascular endothelial cells and hypothesized that CNP might be a local regulator of vascular tone and/or growth from endothelial cells. In order to clarify the pathophysiological significance of CNP in humans, we examined the presence of CNP in human circulation and determined plasma levels of CNP in patients with various cardiovascular disorders. The plasma level of CNP in healthy persons was 1.4 +/- 0.6 fmol/ml (n = 13). The plasma level of CNP was markedly increased in patients with septic shock (13.2 +/- 10.1 fmol/ml, n = 11), while there was no alteration in patients with congestive heart failure or hypertension. There was two-fold increase of the plasma CNP level in patients with chronic renal failure. These results indicate that CNP, which can be considered as an endothelium-derived relaxing peptide, is detectable in human circulation and suggest the pathophysiological significance of endothelial CNP in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117275     DOI: 10.1006/bbrc.1994.1166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Characterization of a C-type natriuretic peptide (CNP-39)-formed cation-selective channel from platypus (Ornithorhynchus anatinus) venom.

Authors:  J I Kourie
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

2.  C-type natriuretic peptide modulates permeability of the blood-brain barrier.

Authors:  Manoj Bohara; Yuki Kambe; Tetsuya Nagayama; Hiroshi Tokimura; Kazunori Arita; Atsuro Miyata
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

Review 3.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

4.  Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags.

Authors:  Ang Swee Siang; Robin Doley; Freek J Vonk; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2010-03-29       Impact factor: 2.946

Review 5.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

6.  Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-A.

Authors:  Catherine M Panayiotou; Reshma Baliga; Raymond Stidwill; Valerie Taylor; Mervyn Singer; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

7.  Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.

Authors:  Sharmila D Chauhan; Holger Nilsson; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

Review 8.  Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases.

Authors:  Kazuwa Nakao; Akihiro Yasoda; Ken Ebihara; Kiminori Hosoda; Masashi Mukoyama
Journal:  J Mol Med (Berl)       Date:  2009-10       Impact factor: 4.599

Review 9.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

10.  Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.

Authors:  B Nazario; R M Hu; A Pedram; B Prins; E R Levin
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.